by ComplianceQuest

Inspection Tracker

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

FDA Guidance Global Templates

Start with a Free ConsultationBook 30 minutes with a ComplianceQuest specialist.Book a Call

Sign In Create a Free Account

Big News: FDA is moving from MasterControl to ComplianceQuest.See Why

Search AgentQ/

Talk to a Specialist

Loading…

My DashboardInspection TrackerWarning LettersShimoga Chemicals

All Warning Letters

Shimoga Chemicals

Warning LetterOpen

W57A, MIDC, Kupwad Sangli 416436 Maharashtra IndiaFEI 3033881432Issued Jul 13, 2026Center for Drug Evaluation and Research (CDER)

Source: FDA, published letter. FDA published this warning letter; View Letter opens FDA's copy. To check it, open FDA's record for this establishment, listed under FEI 3033881432.

Violations3

Issue DateJul 13, 2026

Product TypeDrugs

StatusOpen

Letter Details

Firm: Shimoga Chemicals
Location: W57A, MIDC, Kupwad Sangli 416436 Maharashtra India
FEI Number: 3033881432
Country: India
Issue Date: July 13, 2026
Issuing Office: Center for Drug Evaluation and Research (CDER)
Product Type: Drugs
Status: Open

Subject

CGMP/Active Pharmaceutical Ingredient (API)/Adulterated

Shimoga Chemicals FDA Warning Letter, July 13, 2026